PBL - Innovation in Life Sciences
Early Stage Technology Investment, IP Management and Licensing
PBL develops innovative technologies from public and private sources worldwide - turning ideas into patented, scientifically validated and licensable technologies. PBL invests in building intellectual property protection, and develops technologies through proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors. Our interests cover AgBiotech, Food / Nutrition, Microbiology, Biotechnology and related Life Science industries. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners.
PBL was formed in 1994, and is now jointly and equally owned by The John Innes Centre, The Sainsbury Laboratory, and the BBSRC (Biotechnology and Biological Sciences Research Council).
Technology Investment Services for Public Sector Researchers
We offer various options for our services but most commonly work on a fully contingent, non-fee basis, instead taking a portion of future commercial revenues, shared with the original source of the technology. We commonly cover patent costs and can inject funds directly to carry out critical proof-of-concept or technology development work.
Please click here for more information.
IP Management and Patent Advisory Service for Bioscience Companies and Investors
PBL offers bioscience companies and investors a patent consultation and management service including: IP identification and assessment; IP strategy definition; IP portfolio management; IP due diligence.
Please click here for more information.

|
|
Latest News
Major Crop Technology Licensed 12 May 08 More Info...
Novacta Biosystems Receives £3.2m Wellcome Trust Award 14 Jan 08 More Info...
INRA Transfert and PBL join forces in technology promotion alliance 7 Jan 08 More Info...
PBL Helps Researchers Win £422,000 for Developing Promising Innovations 14 Dec 07 More Info...
PBL is Building its Portfolio in Crop Pest Control: BBSRC Follow-on Fund Provides Further Support 14 Dec 07 More Info...
PBL Signs Agreement to Promote PBL Technologies in India and South East Asia 14 Dec 07 More Info...
Viral “Armour” for RNA Control Sequences 12 Dec 07 More Info...
PBL Acquires Novel Adjuvant Technology 12 Dec 07 More Info...
The Financial Times - Procarta Biosystems Grabs Headlines 3 Dec 07 More Info...
|